ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/03/20 | 1,826 | 1,835 | 1,771 | 1,788 | -36 | -2% | 633,400 |
2023/03/17 | 1,787 | 1,824 | 1,781 | 1,824 | +35 | +2% | 486,300 |
2023/03/16 | 1,755 | 1,800 | 1,755 | 1,789 | +4 | +0.2% | 522,500 |
2023/03/15 | 1,792 | 1,802 | 1,768 | 1,785 | +9 | +0.5% | 612,600 |
2023/03/14 | 1,779 | 1,805 | 1,760 | 1,776 | -16 | -0.9% | 660,200 |
2023/03/13 | 1,800 | 1,809 | 1,776 | 1,792 | -48 | -2.6% | 730,800 |
2023/03/10 | 1,852 | 1,872 | 1,831 | 1,840 | -33 | -1.8% | 805,800 |
2023/03/09 | 1,836 | 1,883 | 1,835 | 1,873 | +54 | +3% | 931,300 |
2023/03/08 | 1,818 | 1,838 | 1,809 | 1,819 | +5 | +0.3% | 680,200 |
2023/03/07 | 1,788 | 1,818 | 1,782 | 1,814 | +9 | +0.5% | 747,300 |
2023/03/06 | 1,822 | 1,833 | 1,798 | 1,805 | +8 | +0.4% | 512,900 |
2023/03/03 | 1,775 | 1,806 | 1,771 | 1,797 | +37 | +2.1% | 599,800 |
2023/03/02 | 1,750 | 1,770 | 1,737 | 1,760 | -24 | -1.3% | 756,900 |
2023/03/01 | 1,849 | 1,854 | 1,766 | 1,784 | -65 | -3.5% | 1,141,400 |
2023/02/28 | 1,848 | 1,871 | 1,821 | 1,849 | +61 | +3.4% | 927,100 |
2023/02/27 | 1,786 | 1,808 | 1,771 | 1,788 | -49 | -2.7% | 752,500 |
2023/02/24 | 1,810 | 1,857 | 1,760 | 1,837 | +12 | +0.7% | 1,110,000 |
2023/02/22 | 1,810 | 1,835 | 1,794 | 1,825 | -20 | -1.1% | 750,800 |
2023/02/21 | 1,891 | 1,910 | 1,837 | 1,845 | -30 | -1.6% | 889,500 |
2023/02/20 | 1,851 | 1,891 | 1,837 | 1,875 | -12 | -0.6% | 660,900 |
2023/02/17 | 1,898 | 1,911 | 1,837 | 1,887 | -47 | -2.4% | 1,667,900 |
2023/02/16 | 1,894 | 1,966 | 1,894 | 1,934 | +54 | +2.9% | 1,263,000 |
2023/02/15 | 1,960 | 1,992 | 1,875 | 1,880 | -206 | -9.9% | 2,698,200 |
2023/02/14 | 2,071 | 2,098 | 2,063 | 2,086 | +9 | +0.4% | 672,900 |
2023/02/13 | 2,045 | 2,091 | 2,041 | 2,077 | +14 | +0.7% | 467,200 |
2023/02/10 | 2,106 | 2,106 | 2,041 | 2,063 | -44 | -2.1% | 889,800 |
2023/02/09 | 2,040 | 2,117 | 2,037 | 2,107 | +42 | +2% | 913,800 |
2023/02/08 | 2,035 | 2,069 | 2,000 | 2,065 | +38 | +1.9% | 910,400 |
2023/02/07 | 2,011 | 2,058 | 2,007 | 2,027 | +27 | +1.4% | 991,700 |
2023/02/06 | 2,020 | 2,041 | 1,993 | 2,000 | +2 | +0.1% | 588,300 |
2023/02/03 | 2,020 | 2,029 | 1,990 | 1,998 | +5 | +0.3% | 482,600 |
2023/02/02 | 1,983 | 2,003 | 1,954 | 1,993 | +20 | +1% | 638,000 |
2023/02/01 | 2,016 | 2,026 | 1,971 | 1,973 | -35 | -1.7% | 1,024,300 |
2023/01/31 | 2,009 | 2,039 | 1,997 | 2,008 | -16 | -0.8% | 618,200 |
2023/01/30 | 2,046 | 2,058 | 2,010 | 2,024 | -9 | -0.4% | 620,400 |
2023/01/27 | 2,065 | 2,065 | 2,023 | 2,033 | -42 | -2% | 737,900 |
2023/01/26 | 2,088 | 2,120 | 2,055 | 2,075 | +6 | +0.3% | 917,300 |
2023/01/25 | 2,060 | 2,081 | 2,022 | 2,069 | -23 | -1.1% | 1,258,200 |
2023/01/24 | 2,069 | 2,146 | 2,060 | 2,092 | +60 | +3% | 1,769,500 |
2023/01/23 | 2,034 | 2,069 | 2,025 | 2,032 | +7 | +0.3% | 899,200 |
2023/01/20 | 1,994 | 2,038 | 1,983 | 2,025 | -5 | -0.2% | 1,215,100 |
2023/01/19 | 2,150 | 2,172 | 2,014 | 2,030 | -20 | -1% | 3,804,300 |
2023/01/18 | 2,020 | 2,061 | 1,984 | 2,050 | +44 | +2.2% | 1,250,600 |
2023/01/17 | 2,049 | 2,062 | 1,972 | 2,006 | -23 | -1.1% | 713,300 |
2023/01/16 | 2,036 | 2,070 | 2,007 | 2,029 | -16 | -0.8% | 769,000 |
2023/01/13 | 2,040 | 2,070 | 2,032 | 2,045 | -19 | -0.9% | 764,000 |
2023/01/12 | 2,057 | 2,093 | 2,038 | 2,064 | +14 | +0.7% | 820,000 |
2023/01/11 | 1,984 | 2,061 | 1,973 | 2,050 | +67 | +3.4% | 1,110,100 |
2023/01/10 | 1,985 | 2,010 | 1,944 | 1,983 | -39 | -1.9% | 1,658,800 |
2023/01/06 | 1,993 | 2,067 | 1,984 | 2,022 | +12 | +0.6% | 1,580,600 |
501~
550
件表示中 / 2888件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 193,900円 | +5.0% | +1.5% | 0.00% | 16.65倍 | 4.43倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
ツムラ | 420,100円 | +20.9% | +87.3% | 3.24% | 9.38倍 | 1.08倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サワイGHD | 193,700円 | +4.0% | +25.4% | 2.74% | 8.47倍 | 1.11倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
住友ファーマ | 62,100円 | +21.1% | - | 0.00% | 15.42倍 | 2.16倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
日本新薬 | 350,400円 | +7.9% | +8.9% | 3.54% | 7.50倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム